Keywords = HER2
| Number of Articles: 11 | ||||
| 1 | Tissue ELISA and Serum Amperometric Magnetoimmunosensor of ECD-HER2 In Stratifying Subtyping of Egyptian Woman Breast Cancers | |||
| Articles in Press, Accepted Manuscript , Available Online from 05 October 2022 | ||||
| Sameh Fawzy Nakhla; Zynab Elwafe; Ahmed Saad Saad; Tarek Aref; Noha Ragab; inas elbadry; Unai Eletxigerra Eletxigerra; Susana Campuzano; Jesus Martínez-Perdiguero; Santos Merino Merino; José M. Pingarrón; Salah Abdelmoneim; Eman El-Abd | ||||
| 2 | 6-aminomethylpinostrobin Derivatives as Anti-breast Cancer: In Silico Insight | |||
| Volume 67, Issue 7, July 2024, Page 71-81 | ||||
| Hadi Poerwono; Melanny Ika Sulistyowati; Mohammad Rizki Fadhil Pratama | ||||
| 3 | Evaluation of Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and its Association with Clinicopathological Variables in Patients with Pancreatic Duct Adenocarcinoma in Upper Egypt | |||
| Volume 19, Issue 2, December 2023, Page 31-38 | ||||
| Maisa H. Mohammed; Nagwa A. Ahmed; Maha M. A. Ahmed; Mohammed H. Sayed | ||||
| 4 | Tumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases | |||
| Volume 18, Issue 2, December 2022, Page 45-51 | ||||
| Elia F. Hakim; Amina M. Mostafa; Mohamed A. H. Mohamed; Mahmoud F. A. Sherif; Maha S. El Naggar | ||||
| 5 | Prognostic Value of SMAD4 Expression in Pancreatic Ductal Adenocarcinoma and its Correlation with Clinicopathological Parameters and HER2 Status | |||
| Volume 89, Issue 1, October 2022, Page 5040-5050 | ||||
| walaa ahmed yusuf; Heba Sheta; Hend Mohamed Hamdey Rashed Elkalla; Sylvia Albair Ashamallha; Asmaa Mohammed Ibrahim Gado | ||||
| 6 | Prognostic Value of HER2 in Metastatic Colorectal Cancer: A Single Institutional Experience | |||
| Volume 88, Issue 1, July 2022, Page 2496-2502 | ||||
| Mai Ezz El Din; Radwa Abd El-Azeem Yassin; Mohamed Mohamed El Bassiouny; Manal Mohamed El-Mahdy; Mohamed Yassin Mostafa | ||||
| 7 | Study of HER2 in Breast Cancer Disease | |||
| Volume 64, Issue 12, December 2021, Page 7107-7112 | ||||
| Baraa R. Mhmood; Thikra A. Allwsh | ||||
| 8 | EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value | |||
| Volume 17, Issue 1, June 2021, Page 9-16 | ||||
| Mayada S. Farrag; Ziad Emarah; Waleed Elrefaie; Nesrine S. Farrag; Mohamed T. Hafez; Khaled Abdelwahab | ||||
| 9 | Role of HER2 and Claudins in Subtypes of Urothelial Carcinoma Identified Bygata3 and Cytokeratin5\6 Immunohistochemical Study | |||
| Volume 38, Academic issue, February 2021, Page 128-146 | ||||
| Eman Saad; Kareem Ibrahim; Nashwa Emaraa; Amr El-Sebaaie; Eman omar; Samia youssef | ||||
| 10 | Evaluation of (PARP-1) Expression in Gastric Carcinoma by Immunohistochemistry and Quantitative Real-Time PCR and its Relation to HER2 Status | |||
| Volume 88, September, September 2020, Page 1581-1587 | ||||
| MARWA S. ABD ALLAH, M.D.; HEBA M. ABD EL KARIEM, M.D.; HEBA M. RASHAD, M.D. | ||||
| 11 | INVESTIGATING THE EFFECT OF DIFFERENT ANIMAL VENOMS ON BREAST CANCER CELL LINES (MCF-7): IN VITRO STUDY | |||
| Volume 49, Issue 1, April 2019, Page 28-38 | ||||
| ABIR A. EL-FIKY; HADY S. SHAHIN; ALY F. MOHAMED; SALMA M. EL-RAYES | ||||
| | ||||
View on SCiNiTO